Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 5/20 | 0.53 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | ALB | P02768 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10446528 | 0.92 | RNASE1 (0.63) | TK1RNASE1LMNATSHRALB | |
| SCHEMBL10292555 | 0.92 | RNASE1 (0.63) | TK1RNASE1LMNATSHRALB | |
| SCHEMBL25492060 | 0.88 | LMNA (0.55) | TK1RNASE1LMNATSHRPMP22 | |
| SCHEMBL12932156 | 0.85 | RNASE1 (0.63) | TK1RNASE1 | |
| SCHEMBL15498284 | 0.85 | RNASE1 (0.63) | TK1RNASE1 | |
| SCHEMBL15498298 | 0.85 | RNASE1 (0.63) | TK1RNASE1 | |
| SCHEMBL15187886 | 0.85 | RNASE1 (0.63) | TK1RNASE1 | |
| SCHEMBL25752765 | 0.85 | TOP2A (0.60) | TK1RNASE1 | |
| SCHEMBL12087585 | 0.84 | TK1 (0.60) | TK1RNASE1LMNAALBPKM | |
| SCHEMBL12015131 | 0.84 | TK1 (0.60) | TK1RNASE1LMNAALBPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230175030-A1 | NUCLEIC ACID POLYMER WITH AMINE-MASKED BASES | Nuclera Nucleics Ltd. (GB) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230175030-A1 | NUCLEIC ACID POLYMER WITH AMINE-MASKED BASES | RNGTT, POLM, POLRMT | TK1 259/4885RNASE1 26/4885LMNA 568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.